Dr. Randhawa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6445 Main St
# OPC24
Houston, TX 77030Phone+1 713-441-9948Fax+1 713-790-6470
Education & Training
- University of Texas M.D. Anderson Cancer CenterFellowship, Leukemia, 2014 - 2015
- Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 2011 - 2014
- Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2008 - 2010
- Dayanand Medical College Class of 2005
Certifications & Licensure
- WI State Medical License 2009 - 2025
- TX State Medical License 2017 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 9 citationsOral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised...Guillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, Karen W L Yee, Amer M Zeidan
The Lancet. Haematology. 2024-01-01 - 4 citationsPrimary CNS Lymphoma Arising from the 4th Ventricle: A Case Report and Review of the LiteratureAva Brozovich, Donald C. Ewing, Ethan Burns, Courtney Hatcher, Gonzalo Acosta
Case Reports in Oncological Medicine. 2019-04-10 - 13 citationsA Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid LeukemiaIman Abou Dalle, Jorge E. Cortes, Pramod Pinnamaneni, Betty Lamothe, Adolfo Enrique Diaz Duque
Acta Haematologica. 2018-09-01
Journal Articles
- Final Outcomes of Escalated Melphalan 280 mg/m2 with Amifostine Cytoprotection Followed Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: High C...Neal Flomenberg, Dianna S Howard, Barry R Meisenberg, Parameswaran Hari, Gordon L Phillips, David H Vesole, Jasleen Randhawa, Aaron P Rapoport, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: